phagy is simultaneously a mode of programmed cell death and an important physiological process for cell survival, but its pathophysiological significance in cardiac myocytes remains largely unknown. We induced autophagy in isolated adult rat ventricular cardiomyocytes (ARVCs) by incubating them in glucose-free, mannitol-supplemented medium for up to 4 days. Ultrastructurally, intracellular vacuoles containing degenerated subcellular organelles (e.g., mitochondria) were markedly apparent in the glucose-starved cells. Microtubule-associated protein-1 light chain 3 was significantly upregulated among the glucose-starved ARVCs than among the controls. After 4 days, glucose-starved ARVCs showed a significantly worse survival rate (19 Ϯ 5.2%) than the controls (55 Ϯ 8.3%, P Ͻ 0.005). Most dead ARVCs in both groups showed features of necrosis, and the rate of apoptosis did not differ between the groups. Two inhibitors of autophagy, 3-methyladenine (3-MA) and leupeptin, significantly and dose-dependently reduced the viability of both control and glucose-starved ARVCs and caused specific morphological alterations; 3-MA reduced autophagic findings, whereas leupeptin greatly increased the numbers and the sizes of vacuoles that contained incompletely digested organelles. The knockdown of the autophagy-related genes with small interfering RNA also reduced the glucose-starved ARVCs viability, but rapamycin, an autophagy enhancer, improved it. Reductions in the ATP content of ARVCs caused by glucose depletion were exacerbated by the inhibitors while attenuated by rapamycin, suggesting that autophagy inhibition might accelerate energy depletion, leading to necrosis. Taken together, our findings suggest that autophagy in cardiomyocytes reflects a prosurvival, compensatory response to stress and that autophagic cardiomyocyte death represents an unsuccessful outcome due to necrosis.
somes are recruited to maintain ATP production and protein synthesis, thereby promoting cell survival. Autophagic cell death is actually a morphological term derived from electron microscopic observations and denotes a form of cell death in which abundant autophagic vacuoles are present in the cytoplasm. But this definition tells us nothing about the pathophysiological significance of autophagy in disease processes. Consequently, although cardiomyocytes showing characteristics of autophagy have recently been reported in failing hearts, suggesting autophagic hyperfunction (6, 10, 11, 23, 27) , it is still undetermined whether an abnormal increase in autophagic vacuoles is the primary cause of cardiomyocyte death in heart failure or even whether it reflects hyperfunction or hypofunction of the autophagic process. Danon's disease may epitomize the complicated issue of autophagy in the heart. In this disease, digestion of the contents of autophagic vacuoles is impaired (hypofunction) due to a gene-related deficiency in the lysosomal enzyme lysosome-associated membrane protein-2 (LAMP-2), which results in accumulation of autophagolysosomes with undigested contents in the cytoplasm and cardiomyocyte death, ultimately leading to heart failure (18, 25) . Thus, autophagic hypofunction is apparently detrimental in the case of Danon's disease.
Our aim in the present study was to test whether basal and starvation-induced autophagy are protective or detrimental processes in cultured adult rat ventricular cardiomyocytes (ARVCs). For that purpose, we inhibited or enhanced autophagy by using several reagents and small interfering RNA (siRNA) and then assessed the survival rates among the cells and the ultrastructural changes they underwent.
MATERIALS AND METHODS
ARVC isolation and culture. This study was approved by our Institutional Animal Research Committee and conformed to the animal care guidelines of the American Physiological Society. We isolated ARVCs from male Sprague-Dawley rats (200 to 250 g) as previously described (14) . The cells were plated on laminin-coated dishes or slide glass chambers at the concentration of 5.0 ϫ 10 4 cells/ml and incubated in DMEM containing 50 g/ml gentamicin in a CO 2 incubator (95% room air-CO2).
Cell treatments. One day after plating, the normal culture medium of some ARVCs was replaced with glucose-free DMEM (No. 11966, GIBCO), in which glucose was substituted with 11 mM mannitol to induce starvation-induced autophagy, and the cells were incubated for up to 4 days. Cells incubated in glucose (11 mM)-containing medium served as controls. In some experiments, an inhibitor of autophagy, either 3-methyladenine (3-MA; an inhibitor of phagophore formation; Sigma-Aldrich) or leupeptin (an inhibitor of lysosomal cysteine protease to suppress subsequent digestion of the contents within autophagolysosomes; Sigma-Aldrich) (27) , was added when the medium was changed. Rapamycin (an inhibitor of mammalian target of rapamycin, which negatively controls autophagy by mediating class I phosphatidylinositol 3-kinases, Sigma-Aldrich) was alternatively used in an attempt to enhance autophagy (19) . Because 3-MA and leupeptin are not specific inhibitors of autophagy, we attempted the knockdown of ATG5 and LAMP-2 using siRNA delivered by lentivirus. ARVCs were incubated in virus-containing medium for 24 h and then exposed to starvation. The efficiency of transfection (%positive) was calculated by counting green fluorescent protein (GFP)-positive cells in five random high-power fields (ϫ400) of ARVCs transfected with a lentiviral GFP expression vector at 24 h after lentivirus mediated GFP transfection.
Lentivirus-mediated delivery of siRNA. The oligonucleotides used for siRNA were as follows: ATG5-1 sense, GCGGATTCCAACG-TGCTTTA; ATG5-1 antisense, TAAAGCACGTTGGAATCCGC; ATG5-2 sense, GTCAGGTGATCAACGAAAT; ATG5-2 antisense, ATTTCGTTGATCACCTGAC; LAMP-2-1 sense, GCAGTTGTG-GCGATGATAA; LAMP-2-1 antisense, TTATCATCGCCA-CAACTGC; LAMP-2-2 sense, GCTGAACAACAGCCAAATT; and LAMP-2-2 antisense, AATTTGGCTGTTGTTCAGC. A nonsilencing control sequence was designed according to the sequences of a negative-control siRNA purchased from B-Bridge International. Every siRNA construct was made using pSINsi-mU6 vector (Takara Bio), and the siRNA-producing constructs were introduced to lentivirus vector plasmid (pLenti6/V5-D-TOPO vector; Invitrogen). We produced lentiviral stocks in 293FT cells following the manufacturer's protocol (Invitrogen).
The efficiency of knockdown was examined by total RNA isolation, cDNA synthesis, and real-time PCR using the transfected rat cardiomyoblasts H2c9 as previously described (26) . Primer sequences used for quantification of ATG5, LAMP-2, and GAPDH were as follows: ATG5 sense, 5Ј-GACGCTGGTAACTGACAA-AGTGA-3Ј; ATG5 antisense, 5Ј-TAGGAGATCTCCAAGGGTA-TGCA-3Ј; LAMP-2 sense, 5Ј-CTGGCTACCATGGGGCTGCA-3Ј; LAMP-2 antisense, 5Ј-ATCCAGTATGATGGCGCTTGAGA-3Ј; GAPDH sense, 5Ј-TTGCCATCAACGACCCCTTC-3Ј; and GAPDH antisense, 5Ј-TTGTCATGGATGACCTTGGC-3Ј. Transfection of ARVCs was performed by replacing the culture medium with viruscontaining medium for 24 h.
Cell morphology and membrane permeability. ARVCs were morphologically classified into two groups according to the cell lengthto-cell width ratio. Cells with a cell length-to-cell width ratio of Ͼ3 were classified as rod shaped, whereas those with cell length-to-cell width ratios of Ͻ3 were deemed not to be rod shaped (8) . The latter included square cells and round cells, which in some cases also showed budding or blebbing and cellular fragmentation. The viability of the cells was assessed by exposing them to 0.1% Trypan blue for 5 min, after which the numbers of stained (indicative of sarcolemmal damage) and unstained cells were counted (7) . Experiments were done in triplicate in each group.
Electron microscopy. ARVCs on slide chambers were fixed for 4 h in phosphate-buffered 2.5% glutaraldehyde (pH 7.4) and then postfixed for 1 h in 1% osmium tetroxide. They were then conventionally prepared for transmission electron microscopy (H-800, Hitachi, Tokyo, Japan).
Immunofluorescence microscopy. After ARVCs were fixed on slide chambers with 4% paraformaldehyde, the cells were double labeled first with anti-microtubule-associated protein-1 light chain 3 (LC3; Santa Cruz Biotechnology) and anti-␣-sarcomeric actinin (Sigma) and then, respectively, with Alexa 488-and 568-conjugated secondary antibodies (Molecular Probes). Hoechst 33342 was used for nuclear staining. The immunostained preparations were observed under a confocal microscope (LSM510, Zeiss).
Measurement of ATP content. The total ATP levels within ARVCs were determined using an ATP Bioluminescent Assay Kit (Sigma), following the manufacturer's instructions. After we harvested the cells by centrifugation at 4,500 g for 5 min at 4°C, ATP was extracted from the cell pellets by incubating with 1% trichloroacetic acid-4 mM EDTA solution for 10 min on ice. The extracts were then collected and centrifuged at 12,000 g for 10 min at 4°C, after which the supernatants were used for ATP determination. Experiments were done in triplicate.
Western blot analysis. Proteins extracted from ARVCs were subjected to 14% polyacrylamide gel electrophoresis and then transferred onto polyvinylidene difluoride membranes. The membranes were then probed using primary antibodies against LC3 (Santa Cruz Biotechnology) and the cleaved forms of caspase-3 (Cell Signaling), after which the blots were visualized using enhanced chemiluminescence (Amersham). ␣-Tubulin (analyzed using an antibody from Santa Cruz) served as the loading control. Experiments were done in triplicate.
Statistical Analysis
Values were expressed as means Ϯ SE. Statistical comparisons were made using t-tests or ANOVA followed by Newman-Keuls multiple comparisons test. Values of P Ͻ 0.05 were considered significant. 
RESULTS
ARVC viability and morphology. The survival rate among control ARVCs, as indicated by Trypan blue dye exclusion, gradually declined until it reached 55 Ϯ 8.3% after 4 days of incubation (Fig. 1A) . Survival declined more steeply among the glucose-starved ARVCs and reached 19 Ϯ 5.2% (P Ͻ 0.005 vs. control) after 4 days of incubation (Fig. 1A) . Nonetheless, the incidences of apoptosis, as indicated by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) positivity, were similar among the control and glucose-starved cells after 4 days of incubation (Fig. 1B) .
Necrotic ARVCs were often observed in both groups. Under electron microscopic examination, these necrotic cells showed disrupted plasma membranes, mitochondria that were swollen and containing flocculent dense bodies, and sarcomeres that were supercontracted (Fig. 2) . In living ARVCs in both groups, membrane-bound autophagic vacuoles were apparent, within which were intracellular organelles (mostly mitochondria) being digested. Notably, these vacuoles were much more numerous in the glucosestarved ARVCs than in the controls (Fig. 2) .
Immunohistochemical analysis revealed that control ARVCs expressed some LC3 (Fig. 3) , but comparatively small numbers of LC3-positive "dots" were seen (3.5 Ϯ 0.7 dots/cell). By contrast, glucose-starved cells expressed an abundance of LC3-positive dots (21 Ϯ 1.5 dots/cell, P Ͻ 0.05). The dots were also observed in necrotic ARVCs with damaged plasma membranes but were not seen in apoptotic ARVCs (Fig. 3) . Western blot analysis revealed that LC3-II was significantly increased in the glucose-starved ARVCs (Fig. 4) .
Intervention in ARVC autophagy. We used 3-MA and leupeptin to examine the effects of inhibiting autophagy in these cells. Both inhibitors dose-dependently reduced viability among control and glucose-starved ARVCs after 3 days of incubation (Fig. 5A) , suggesting that the inhibition of either basal or starvation-induced autophagy is detrimental to the isolated ARVCs. In contrast, the treatment with rapamycin significantly attenuated the starvation-induced death of ARVCs in a dose-dependent manner (Fig. 5A) .
The inhibition of autophagy by 3-MA or leupeptin increased the numbers of necrotic ARVCs but had no effect on apoptosis, i.e., no effect on the incidence of TUNEL-positive cells or caspase-3 activation (Fig. 5, B and C) . Rapamicin did not affect apoptosis either. Moreover, the two inhibitors induced ultrastructural changes that were specific to each, particularly in living ARVCs (Fig. 6 ). Treatment with 3-MA markedly reduced the numbers of autophagic vacuoles in glucose-starved ARVCs, irrespective of whether they were living or dead (Fig.  6, A and B) . By contrast, the numbers of autophagic vacuoles and their size were greatly increased in the leupeptin-treated ARVCs (Fig. 6, C-F) . Within the enlarged autophagolysosomes was an abundance of incompletely digested mitochondria and other membranous structures. Rapamycin increased the vacuoles containing digested organelles and also empty vacuoles; the latter might be phagophore or autophagolysosome that finished digestion of the contents (Fig. 6G) .
The LC3-immunopositive dots were significantly decreased in the glucose-starved ARVCs by the treatment with 3-MA, whereas they were increased by leupeptin and rapamycin. Such immunofluorescent findings were supported by the Western blot analysis for LC3-II (Fig. 4) . The increase of LC3-II in the leupeptin-treated ARVCs may be explained by the accumulation of undigested LC3-II.
We next performed experiments using siRNAs for ATG5 to specifically inhibit the initiation step of autophagy (formation of phagophore) and also siRNAs for LAMP-2 to inhibit the digestion step of autophagy. We generated two siRNA constructs directed against different regions of ATG5 (ATG5-1 and ATG5-2) and two siRNA against LAMP-2 (LAMP-2-1 and LAMP-2-2). ATG5-1 and ATG5-2 decreased the expression of ATG5 at mRNA level, whereas LAMP-2-1 and LAMP-2-2 decreased the expression of LAMP-2 at mRNA level (Fig.  7A) . However, the transfection efficiency was relatively low: only 29 Ϯ 2.3% assessed by GFP expression in ARVCs transfected with a lentiviral GFP expression vector. Despite such poor transfection efficiency, all siRNA significantly, though not markedly, decreased the viability of the ARVCs exposed to glucose depletion for 3 days (Fig. 7B) , although no effect of siRNAs was seen upon cell survival in nonstarved cells (basal autophagy), probably because basal autophagy is originally low level and because transfection efficiency was substantially low. We evaluated the effect of siRNAs upon autophagy by counting LC3-positive dots in the glucosestarved cardiomyocytes under confocal microscopy. When compared with the control siRNA (23 Ϯ 1.5 dots/cell, n ϭ 6), both ATG5 siRNA significantly reduced the numbers of dots (18 Ϯ 0.62 in ATG5-1, and 19 Ϯ 0.71 in ATG5-2, n ϭ 6 each), whereas both LAMP-2 siRNA significantly increased them (36 Ϯ 0.60 in LAMP-2-1, and 34 Ϯ 0.54 in LAMP-2-2, n ϭ 6 each) (photographs not shown). ATP content in ARVCs. The reduction in the intracellular ATP content is known to be tightly related to necrosis in cardiomyocytes (21) . Since we observed that the incidence in necrosis was increased among glucose-starved ARVCs and that this necrosis was accelerated by inhibition of autophagy, we next measured the ATP contents in the ARVCs. We found the ATP content to be significantly diminished in the glucosestarved ARVCs after 3 days of incubation (1.59 Ϯ 0.14 ϫ10 Ϫ10 mol/g protein) compared with controls (2.41 Ϯ 0.06 ϫ10 Ϫ10 mol/g protein, P Ͻ 0.05). Interestingly, the ATP content was further reduced in both control and glucosestarved cells by treatment with an autophagy inhibitor: in controls, 1.94 Ϯ 0.47 ϫ10 Ϫ10 mol/g protein by 3-MA and 2.09 Ϯ 0.21 ϫ10 Ϫ10 mol/g protein by leupeptin; and in glucose-starved cells, 1.08 Ϯ 0.11 ϫ10 Ϫ10 mol/g protein by 3-MA and 1.18 Ϯ 0.03 ϫ10 Ϫ10 mol/g protein by leupeptin (Fig. 8) . Conversely, the ATP content was significantly increased by the treatment with rapamycin in the glucose-starved cells (2.11 Ϯ 0.25 ϫ10 Ϫ10 mol/g protein). There was thus a significant correlation between reduction in the ATP content of ARVCs and the increase in the incidence of necrosis under both basal conditions and after glucose depletion.
DISCUSSION
Although autophagy is a form of cell death, it is generally accepted that autophagy is also essential for cell survival in cases of nutrient or growth-factor removal (3, 13) . Indeed, Kuma et al. (12) reported that autophagy is necessary for the survival of neonatal mice during periods of starvation after birth. The present study confirmed these findings in ARVCs by showing that two autophagy inhibitors, 3-MA and leupeptin, reduced survival among ARVCs subjected to glucose depletion. Experiments using siRNA for ATG5 and LAMP-2 strengthened the findings in terms of specific inhibition of autophagy. Notably, these inhibitors also reduced survival among control ARVCs without apparent nutrient depletion, suggesting that autophagy plays an essential physiological role necessary for ARVC survival, even under basal culture conditions. That said, the in vitro conditions that the cells experienced in the present study almost certainly differ significantly from the in vivo conditions.
Although both 3-MA and leupeptin inhibit autophagy, their mechanisms of action differ: 3-MA inhibits formation of phagophores, whereas leupeptin suppresses digestion of the contents of autophagolysosomes. The use of leupeptin may mimic the pathophysiological conditions of Danon's disease (18) , and we actually observed the accumulation of gigantic autophagolysosomes containing undigested organelles in ARVCs treated with leupeptin. In contrast, ARVCs treated with 3-MA lacked autophagic features. Despite their differences, both inhibitors caused autophagic hypofunction and markedly accelerated ARVC necrosis, accompanied by a reduction in intracellular ATP. ATP depletion upsets the transmembrane balance of electrolytes by disrupting the activities ATP-dependent ion pumps, thereby causing the cells to become edematous (2, 21) . In addition, ATP depletion disturbs the homeostasis Fig. 7 . Effect of knockdown of ATG5 or lysosome-associated membrane protein-2 (LAMP-2) with small interfering (si)RNAs. A: real-time PCR revealed that lentivirus-delivered siRNAs (ATG5-1 and ATG-2) inhibited the expression of ATG5 gene and that lentivirus-delivered siRNAs (LAMP-2-1 and LAMP-2-2) did that of LAMP-2 gene. B: any siRNAs for ATG5 and LAMP-2 did not affect the survival rate of ARVCs without glucose depletion (left), but survival rate of ARVCs exposed to glucose starvation was reduced significantly, though not markedly, by lentivirus-mediated transfection of siRNAs (right). Such small effects may be explained by the relatively poor transfection efficiency of lentivirus to ARVCs (29 Ϯ 2.3%). Survival rate of the cardiomyocytes-transfected control siRNA was set at 100% in each experiment. *P Ͻ 0.05 compared with the group treated with the control siRNA. maintained by mitochondrial ATP energy production and the synthesis of proteins essential for cell survival. Together, these effects could have caused the cells to eventually become necrotic. Thus the necrosis among ARVCs observed in the present study might be the result of energy depletion (primary necrosis) caused by the prevention of recycled energy production via autophagy. This idea might be supported by the fact that the upregulation of autophagy by rapamycin preserved the ATP content and increased cell survival. However, another possibility is that the ATP levels dropped as the result of cell rupture. It is difficult to strictly determine the cause-and-effect relationship between necrosis and ATP loss in the present study protocol, and to resolve this issue, it would be necessary to monitor the morphology and ATP content in a single cell level.
Earlier studies have shown that expression of autophagic genes is needed for autophagic cell death (20, 22, 29) . Furthermore, the true function of autophagy, whether protective or detrimental, is still controversial in the context of cardiovascular disease. For instance, Akazawa et al. (1) developed a mouse model of diphtheria toxin-induced heart failure in which the cardiomyocytes showed abundant autophagic vacuoles, and in a hamster cardiomyopathy model induced by ␦-sarcoglycan deficiency, we observed severe autophagic degeneration in cardiomyocytes and found that treatment with granulocyte colony-stimulating factor mitigated both the heart failure and the associated autophagic findings (16) . Autophagy may also be an adaptive or maladaptive feature of hearts subjected to pressure overload (17, 30) and was recently highlighted in ischemic heart disease, where it appears to protect ischemic cardiomyocytes (5, 15, 27) . It thus appears that the determination of whether autophagy is protective or detrimental in diseased hearts will require further investigation. However, the findings of the present study suggest that the autophagic degeneration of cultured ARVCs reflects a prosurvival, compensatory response to glucose depletion and that ARVC death may represent the unsuccessful outcome due to necrosis.
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